Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Mol Biol Rep ; 50(2): 1019-1031, 2023 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-36383336

RESUMO

BACKGROUND: The antituberculosis drugs (ATDs), isoniazid, rifampicin, pyrazinamide and ethambutol prompt extreme hepatic and renal damage during treatment of tuberculosis. The present study aimed to investigate protective potential of naringenin against ATDs induced hepato-renal injury. METHODS: Rats were administered with ATDs (pyrazinamide; 210, ethambutol; 170, isoniazid; 85, rifampicin; 65 mg/kg b.wt) orally for 8 weeks (3 days/week) followed by naringenin at three different doses (10, 20 and 40 mg/kg b.wt) conjointly for 8 weeks (3 days/week alternately to ATDs administration) and silymarin (50 mg/kg b.wt) as positive control. RESULTS: Exposure to ATDs caused significant increase in interleukin-6 (IL-6), triglycerides, cholesterol, bilirubin whereas depletion in insulin like growth factor-1 (IGF-1), albumin and glucose in serum. Endogenous antioxidant enzymes glutathione reductase (GR), glutathione peroxidase (GPx) and glucose-6-phosphate-dehydrogenase (G-6-PDH) were diminished in liver and kidney tissues with parallel increase in triglycerides, cholesterol, microsomal LPO and aniline hydroxylase (CYP2E1 enzyme). Ultra-structural observations of liver and kidney showed marked deviation in plasma membranes of various cellular and sub-cellular organelles after 8 weeks of exposure to ATDs. CONCLUSIONS: Conjoint treatment of naringenin counteracted ATDs induced toxic manifestations by regulating IL-6, IGF-1, CYP2E1, biochemical and ultra-structural integrity in a dose dependent manner. Naringenin has excellent potential to protect ATDs induced hepato-renal injury by altering oxidative stress, modulation of antioxidant enzymes, serum cytokines and ultra-structural changes.


Assuntos
Antituberculosos , Interleucina-6 , Ratos , Animais , Antituberculosos/toxicidade , Interleucina-6/metabolismo , Isoniazida/toxicidade , Isoniazida/metabolismo , Pirazinamida/metabolismo , Pirazinamida/farmacologia , Etambutol/toxicidade , Etambutol/metabolismo , Rifampina/toxicidade , Rifampina/metabolismo , Fator de Crescimento Insulin-Like I/metabolismo , Citocromo P-450 CYP2E1/metabolismo , Citocromo P-450 CYP2E1/farmacologia , Ratos Wistar , Fígado/metabolismo , Antioxidantes/farmacologia , Antioxidantes/metabolismo , Estresse Oxidativo
2.
Tokai J Exp Clin Med ; 41(1): 14-21, 2016 Mar 20.
Artigo em Inglês | MEDLINE | ID: mdl-27050890

RESUMO

BACKGROUND: Tuberculosis (TB) is an infectious disease of international health priority. The combination of anti-TB drugs (4-Tabs)- isoniazid (INH), rifampicin (RIF), pyrazinamide (PZA) and ethambutol (ETB) are effective in the management of the disease, however, their toxic effect is a major concern. PURPOSE: The study was designed to evaluate the toxicity of anti-TB drugs in male Wistar rats and possible ameliorative effects of kolaviron (KV), a biflavonoid from Garcinia kola seeds. METHODS: Twenty-eight rats were assigned into four groups; Group 1 (Control) received corn oil, Group 2 (4-Tabs) received therapeutic doses of INH (5 mg/kg), RIF (10 mg/kg), PZA (15 mg/kg) and ETB (15 mg/kg) in combination, Group 3 (4-Tabs + KV) received INH, RIF, PZA, ETB and KV (200 mg/kg) and Group 4 (KV) received KV (200 mg/kg) by oral gavage three times per week for 8 consecutive weeks. RESULTS: Administration of 4-Tabs caused oxidative stress resulting in significant (p = 0.031, 0.027) increase in malondialdehyde levels in the liver and kidney of rats by 101% and 34%, respectively. Also, 4-Tabs caused significant (p = 0.023-0.035) elevation of serum alanine and aspartate aminotransferases by 41% and 48%, creatinine by 252% and total bilirubin by 89%, respectively. In contrast, hepatic and renal antioxidant indices- reduced glutathione, glutathione peroxidase, glutathione-s-transferase and superoxide dismutase were significantly (p = 0.028-0.039) decreased in 4-Tabs-treated rats. Co-administration of KV with 4-Tabs significantly restored the antioxidant parameters and biochemical indices to near normal. CONCLUSION: These findings suggest that anti-TB drugs elicit oxidative damage in liver and kidney of rats while KV protects against the adverse effects via antioxidative mechanism.


Assuntos
Antioxidantes , Antituberculosos/efeitos adversos , Antituberculosos/toxicidade , Flavonoides/farmacologia , Garcinia kola/química , Rim/metabolismo , Fígado/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Alanina Transaminase/metabolismo , Animais , Aspartato Aminotransferases , Etambutol/efeitos adversos , Etambutol/toxicidade , Flavonoides/isolamento & purificação , Glutationa/metabolismo , Glutationa Peroxidase/metabolismo , Isoniazida/efeitos adversos , Isoniazida/toxicidade , Masculino , Malondialdeído/metabolismo , Pirazinamida/efeitos adversos , Pirazinamida/toxicidade , Ratos Wistar , Rifampina/efeitos adversos , Rifampina/toxicidade , Sementes/química
3.
Neuroreport ; 11(10): 2299-302, 2000 Jul 14.
Artigo em Inglês | MEDLINE | ID: mdl-10923689

RESUMO

Zinc-chelating agents, including ethambutol and its metabolite 2,2'(ethylenediamino)-dibutyric acid (EDBA) are toxic to retinal ganglion cells through a glutamate dependent mechanism. We explored whether such cell death was mediated through the caspase family of cysteine proteases. Retinal cultures were treated with EDBA alone, or EDBA plus a variety of known caspase inhibitors, and ganglion cell viability was assayed. EDBA killed 20-30% of ganglion cells. A general caspase inhibitor, BAF, prevented EDBA induced ganglion cell death. Specific inhibitors of caspase-3 and caspase-6 showed a similar ability to BAF in preventing EDBA mediated ganglion cell loss, whereas inhibitors of caspase-8 and caspase-9 were not able to rescue EDBA treated ganglion cells. A caspase-1,4 inhibitor was less effective than BAF. These studies show that a caspase mediated mechanism of apoptosis accents for a portion of EDBA mediated retinal ganglion cell death. This toxicity was mediated by downstream effector caspases, 3 and 6. Caspase inhibitors may prevent ganglion cell death secondary to ethambutol treatment.


Assuntos
Inibidores de Caspase , Quelantes/toxicidade , Inibidores de Cisteína Proteinase/farmacologia , Inibidores Enzimáticos/farmacologia , Etambutol/toxicidade , Etilenodiaminas/toxicidade , Células Ganglionares da Retina/efeitos dos fármacos , Zinco/fisiologia , Animais , Caspase 3 , Caspase 6 , Células Cultivadas , Fármacos Neuroprotetores/farmacologia , Ratos , Ratos Long-Evans , Células Ganglionares da Retina/citologia
4.
Acta physiol. pharmacol. ther. latinoam ; 47(4): 197-202, 1997. tab
Artigo em Inglês | LILACS | ID: lil-206835

RESUMO

To evaluate the risk factors involved in antituberculosis treatment-induced hepatotoxicity. In a retrospective study we analyzed the rate of drug-induced hepatotoxicity in a sample of 456 patients. Patients received a combination of drugs including isoniazid, rifampin, pirazinamide and streptomycinor or ethambutol. The association among hepatotoxicity and several risk factors (age, sex, alcoholism and HIV infection) was studied by univariate methods, stratified analysis and the multiple logistic regression model. Signs of liver injury were found in 9.86 percent of the treated patients. In the logistic model, the adjusted odds ratios (OR) and significance were found as follows: a) for alcoholism, OR=17.31 (95 percent CI:6.35-47.16), p<0.001; b) for HIV infection, OR=3.23 (95 percent CI:1.47-7.11), p=0.003 and c) for female Sex, OR=2.44 (95 percent CI:1.22-4.86), p=0.011. Age was not significantly associated with hepatotoxicity. Alcoholism, HIV infection and female sex were associated with an increased risk of hepatotoxicity in this study.


Assuntos
Humanos , Masculino , Feminino , Criança , Adolescente , Adulto , Pessoa de Meia-Idade , Antituberculosos/toxicidade , Hepatopatias/induzido quimicamente , Fígado/efeitos dos fármacos , Alcoolismo , Etambutol/toxicidade , Infecções por HIV , Isoniazida/toxicidade , Fígado/metabolismo , Modelos Logísticos , Pirazinamida/toxicidade , Estudos Retrospectivos , Rifampina/toxicidade , Fatores de Risco , Fatores Sexuais , Estreptomicina/toxicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA